NIH-funded tool can accurately identify the potentially life-threatening inflammatory disease.
Clinical trials will assess multi-cancer detection tests, among others.
Long-acting HIV treatment demonstrates efficacy in people with challenges taking daily medicine as prescribed
All clinical trial participants will have the opportunity to choose the trial medication.
In-depth study finds brain, immune, and metabolic abnormalities linked to debilitating chronic disease.
An NIH-supported observational study finds that even when women and men get the same amount of physical activity, the risk of premature death is lower for women.
Improved genetic tests more accurately assess disease risk regardless of genetic ancestry.
Study details the unprecedented scale, diversity, and power of the All of Us Research Program.
Findings reinforce the importance of receiving both a COVID-19 vaccine and booster during pregnancy.
NIH-supported study in mice could inform treatments of trauma- and stress-related psychiatric conditions.
Dr. Mooney is expected to join NIH in mid-March.
NIH collaboration has implications for neural-immune system responses and aging.
NIH-supported research highlights need to better understand psilocybin in context of growing psychedelic use.
NIH analysis reveals a significant rise in use of complementary health approaches, especially for pain management
Researchers examined the use of modalities such as yoga, meditation, massage over 20 years.
Proteins could serve as biomarkers that improve diagnosis and guide the development of novel therapies.
NIH study shows higher mortality rates for patients on respiratory support in rural intermediate care units
Findings highlight the importance of providing ICU-level care to rural patients with respiratory failure
NIH study finds distinct immune responses occur quickly when diets change, more research needed to determine health effects.
C. burnetti naturally infects livestock, including goats, sheep and cattle.
NIH researchers found widespread differences in the brains of children with anxiety disorders that improved after treatment.
Findings support the HIV fusion peptide as a promising preventive vaccine target.
Reductions correlated with long-term cardiovascular health improvements in NIH-funded study.
12 minutes 48 seconds ago
News releases from the National Institutes of Health (NIH)Subscribe to NIH News Releases feed